<p>The overall survival curve for patients with favorable IGP risk was significantly different from the curve for patients with unfavorable IGP risk (adjusted p<0.001). There was no significant difference in survival curves between patients with favorable IGP risk and patients with intermediate IGP risk (adjusted p = 0.055), or between patients with unfavorable IGP risk and patients with intermediate IGP risk (adjusted p = 0.596).</p
Survival and disease-free survival time of patients with or without specific gene mutations were ana...
<p><b>(A)</b> Disease Free Survival curve for the total of CRC patients. <b>(B)</b> Overall Survival...
<p>The survival of patients with a low prognostic nutritional index (< 49) was significantly differe...
<p>The overall survival curve for patients with favorable M-IGP risk was significantly different fro...
<p>A. Overall survival by cytogenetics and mutational profiles. Among patients with intermediate cyt...
<p>Survival curves for LGG patients with and without aberrations for grades 2 and 3 (A), grade 2 (B)...
<p>The genetic propensity score is computed as the number of risk alleles across the 22 genome-wide ...
<p>(A) The survival rate was worse in <i>RFC1 80AA</i> (22.2%) patients as compared to the <i>RFC1 8...
<p><b>A.</b> Kaplan-Meier curves for patients from the test set stratified by the median of GPS calc...
<p>Overall survival curves for the good prognostic group (n = 19) and poor prognostic group (n = 114...
Median progression-free survival by gene variants in all patients and in IMDC intermediate risk pati...
<p><i>X</i>-axis displays the number of days from catheterization to death (all-cause mortality). <i...
<p>The low risk group showed significant differences compared with the intermediate and high risk gr...
(A–C) Three groups of patients had good prognoses in the low-risk group, respectively. (D–F) ROC cur...
<p><i>X</i>-axis displays the number of days from index catheterization to death (all-cause mortalit...
Survival and disease-free survival time of patients with or without specific gene mutations were ana...
<p><b>(A)</b> Disease Free Survival curve for the total of CRC patients. <b>(B)</b> Overall Survival...
<p>The survival of patients with a low prognostic nutritional index (< 49) was significantly differe...
<p>The overall survival curve for patients with favorable M-IGP risk was significantly different fro...
<p>A. Overall survival by cytogenetics and mutational profiles. Among patients with intermediate cyt...
<p>Survival curves for LGG patients with and without aberrations for grades 2 and 3 (A), grade 2 (B)...
<p>The genetic propensity score is computed as the number of risk alleles across the 22 genome-wide ...
<p>(A) The survival rate was worse in <i>RFC1 80AA</i> (22.2%) patients as compared to the <i>RFC1 8...
<p><b>A.</b> Kaplan-Meier curves for patients from the test set stratified by the median of GPS calc...
<p>Overall survival curves for the good prognostic group (n = 19) and poor prognostic group (n = 114...
Median progression-free survival by gene variants in all patients and in IMDC intermediate risk pati...
<p><i>X</i>-axis displays the number of days from catheterization to death (all-cause mortality). <i...
<p>The low risk group showed significant differences compared with the intermediate and high risk gr...
(A–C) Three groups of patients had good prognoses in the low-risk group, respectively. (D–F) ROC cur...
<p><i>X</i>-axis displays the number of days from index catheterization to death (all-cause mortalit...
Survival and disease-free survival time of patients with or without specific gene mutations were ana...
<p><b>(A)</b> Disease Free Survival curve for the total of CRC patients. <b>(B)</b> Overall Survival...
<p>The survival of patients with a low prognostic nutritional index (< 49) was significantly differe...